Routes to enhanced HIV neuropathogenesis through expression of subclinical levels of endogenous amyloid-beta
通过表达亚临床水平的内源性β淀粉样蛋白增强HIV神经发病机制的途径
基本信息
- 批准号:10415699
- 负责人:
- 金额:$ 247.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-01 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAffectAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease riskAmyloid beta-ProteinAmyloid beta-Protein PrecursorApolipoprotein EApoptosisApplications GrantsBehavioralBiochemicalBioinformaticsBiologicalBiological AssayBiological ProcessBrainBrain DiseasesBrain regionCREB1 geneCa(2+)-Calmodulin Dependent Protein KinaseCell Culture TechniquesCognition DisordersCorpus striatum structureDefectDevelopmentDiseaseDisease ProgressionDoseElementsFunctional disorderGene ExpressionGenesGoalsGrantHIVHIV InfectionsHippocampus (Brain)HumanImmunohistochemistryImpaired cognitionInfectionInjuryInterdisciplinary StudyJointsKnock-in MouseKnowledgeLaboratoriesLate Onset Alzheimer DiseaseLearningLearning DisabilitiesLibrariesLong-Term PotentiationMemoryMemory LossMemory impairmentModelingMolecularMouse StrainsMusMutationMyeloid CellsNeurocognitive DeficitNeuronal PlasticityNeuronsNeuropathogenesisNuclear RNAOnset of illnessOverlapping GenesPathogenesisPathogenicityPathologyPathway interactionsPatientsPersonsPrefrontal CortexProcessProteinsProteolysisReportingResearchResearch Project GrantsRoleRouteSenile PlaquesSeveritiesSiblingsSideSiteSliceSymptomsSynapsesSynaptic plasticitySystemSystems BiologyTestingTranscriptTransgenic OrganismsVirusVirus ReplicationWNT Signaling PathwayWestern BlottingWorkabeta accumulationage relatedage related neurodegenerationamyloid pathologyamyloid precursor protein processingantiretroviral therapybrain cellcalmodulin-dependent protein kinase IIcell typefamilial Alzheimer diseasemouse modelneuropathologynext generationnoveloAβpre-clinicalpreferencesynergismtau Proteinstherapy developmenttranscriptometranscriptome sequencing
项目摘要
This is a resubmission of a collaborative project between HIV and Alzheimer’s Disease (AD) laboratories to
investigate potential synergy between HIV infection and amyloid β (Aβ), a hallmark of AD, in promoting memory
impairment. Half of HIV patients on antiretroviral therapy develop neurocognitive impairments (NCI) despite low
HIV brain burdens. Age is the most consistent factor affecting NCI progression. We reproduced HIV-NCI
pathogenesis in conventional mice infected with EcoHIV, a mouse-tropic HIV. The Project MPI, Dr. Arancio,
reported that non-synaptotoxic doses of exogenous oligomeric Aβ (oAβ) and Tau, another AD hallmark,
cooperate in synaptic dysfunction and memory impairment in mice, suggesting that AD proteins have pathogenic
potential at their subclinical concentrations. Our revised preliminary results show such cooperation between
EcoHIV and oAβ in multiple formats including after EcoHIV infection of AD mouse models prior to their cognitive
decline. The models included transgenic APP/PS1 mouse model of familial AD (FAD) and two late onset AD
(LOAD) mouse models expressing humanized AD proteins. We propose that HIV and subclinical oAβ processes
cooperate in disrupting synaptic plasticity to exacerbate HIV-NCI beyond each agent alone. The Specific Aims
are to: 1) Characterize enhanced HIV-NCI pathogenesis in FAD and LOAD mouse models prior to onset of their
AD symptoms. (A) optimize the onset of memory deficits with EcoHIV infection in preclinical APP/PS1 mice; (B)
determine HIV-NCI severity at disease onset by infected APP/PS1 mice by hippocampal LTP, synaptodendritic
injury, apoptosis, APP processing, and amyloid pathology (C) Conduct similar studies by EcoHIV infection of
LOAD model mice expressing various humanized AD genes and select one LOAD model for further studies 2)
Using APP/PS1 mice and one LOAD strain, conduct next generation RNA sequencing (RNA-seq) in EcoHIV
infected mice upon reaching HIV disease state (A) generate transcriptome from hippocampus (HPC), prefrontal
cortex (PFC), and striatum (STR), and define biological processes specifically associated with memory defects
caused jointly by HIV and oAβ; B) confirm some gene modulation by RT-QPCR in HPC and STR extracts or by
immunostaining in brain section; and C) conduct limited nuclear-RNA-seq analysis in HPC to assign altered HIV-
oAβ processes/transcripts to specific cell types. 3) Study molecular mechanisms responsible for promoting HIV-
NCI pathogenesis in the setting of naturally produced subclinical levels of human oAβ in mice. (A) since both
HIV and Aβ disturb wnt signaling and cause dendritic pruning, examine how HIV infection of myeloid cells works
with Aβ in dysregulating Wnt function in dendritic integrity. B) since EcoHIV downmodulates CaMKII and CREB
in mice study potential Aβ-HIV convergence in oAβ dysregulation of the CREB role in synaptic strengthening.
Studies will include EcoHIV infection of moderate and late onset AD mice, tests of learning and memory, HPC
long-term potentiation, HPC synaptodendritic integrity, apoptosis, APP processing, and amyloid pathology
system and brain HIV burdens, bioinformatics of mouse brain and select cell types.
这是艾滋病毒和阿尔茨海默病 (AD) 实验室之间的合作项目的重新提交
研究 HIV 感染和 AD 标志性淀粉样蛋白 β (Aβ) 在促进记忆方面的潜在协同作用
损害。接受抗逆转录病毒治疗的艾滋病毒患者中有一半会出现神经认知障碍(NCI),尽管其神经认知障碍(NCI)较低
艾滋病毒大脑负担。年龄是影响 NCI 进展的最一致的因素。我们复制了 HIV-NCI
感染EcoHIV(一种小鼠嗜性HIV)的传统小鼠的发病机制。 MPI 项目,Arancio 博士,
报道称,非突触毒性剂量的外源寡聚 Aβ (oAβ) 和 Tau(AD 的另一个标志),
在小鼠的突触功能障碍和记忆障碍中协同作用,表明 AD 蛋白具有致病性
在其亚临床浓度下的潜力。我们修订后的初步结果显示了双方之间的这种合作
EcoHIV 和 oAβ 具有多种形式,包括在 AD 小鼠模型认知之前的 EcoHIV 感染之后
衰退。这些模型包括家族性 AD (FAD) 转基因 APP/PS1 小鼠模型和两种晚发性 AD
(LOAD) 表达人源化 AD 蛋白的小鼠模型。我们认为 HIV 和亚临床 oAβ 过程
合作破坏突触可塑性,使 HIV-NCI 恶化,超出了单独使用每种药物的范围。具体目标
目的是: 1) 在 FAD 和 LOAD 小鼠模型发病前表征增强的 HIV-NCI 发病机制
AD 症状。 (A) 优化临床前 APP/PS1 小鼠中 EcoHIV 感染引起的记忆缺陷的发生; (二)
通过海马 LTP、突触树突确定受感染 APP/PS1 小鼠发病时 HIV-NCI 的严重程度
损伤、细胞凋亡、APP 加工和淀粉样蛋白病理学 (C) 通过 EcoHIV 感染进行类似的研究
表达多种人源化AD基因的LOAD模型小鼠并选择一种LOAD模型进行进一步研究2)
使用 APP/PS1 小鼠和一种 LOAD 品系,在 EcoHIV 中进行下一代 RNA 测序 (RNA-seq)
感染 HIV 的小鼠在达到 HIV 疾病状态后 (A) 从海马 (HPC)、前额叶生成转录组
皮质(PFC)和纹状体(STR),并定义与记忆缺陷特别相关的生物过程
由 HIV 和 oAβ 共同引起; B) 通过 HPC 和 STR 提取物中的 RT-QPCR 或通过
脑切片免疫染色; C) 在 HPC 中进行有限的核 RNA 序列分析,以分配改变的 HIV-
oAβ 对特定细胞类型进行加工/转录。 3) 研究促进HIV-的分子机制
小鼠体内自然产生亚临床水平的人 oAβ 的 NCI 发病机制。 (A) 由于两者
HIV 和 Aβ 干扰 wnt 信号传导并导致树突修剪,检查 HIV 感染骨髓细胞的工作原理
Aβ 导致树突完整性中 Wnt 功能失调。 B) 因为 EcoHIV 下调 CaMKII 和 CREB
在小鼠中研究了潜在的 Aβ-HIV 聚合在 oAβ 失调中的 CREB 在突触强化中的作用。
研究将包括中度和晚期 AD 小鼠的 EcoHIV 感染、学习和记忆测试、HPC
长时程增强、HPC 突触树突完整性、细胞凋亡、APP 加工和淀粉样蛋白病理学
系统和大脑艾滋病毒负担、小鼠大脑和选择细胞类型的生物信息学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OTTAVIO ARANCIO其他文献
OTTAVIO ARANCIO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OTTAVIO ARANCIO', 18)}}的其他基金
Understanding the role of ECSIT in neurodegeneration and Alzheimer's Disease
了解 ECSIT 在神经退行性疾病和阿尔茨海默病中的作用
- 批准号:
10629415 - 财政年份:2021
- 资助金额:
$ 247.5万 - 项目类别:
Understanding the role of ECSIT in neurodegeneration and Alzheimer's Disease
了解 ECSIT 在神经退行性疾病和阿尔茨海默病中的作用
- 批准号:
10216433 - 财政年份:2021
- 资助金额:
$ 247.5万 - 项目类别:
Preclinical development of a novel small molecule inhibitor of Alzheimer's disease-related cognitive impairment
阿尔茨海默病相关认知障碍的新型小分子抑制剂的临床前开发
- 批准号:
10396647 - 财政年份:2020
- 资助金额:
$ 247.5万 - 项目类别:
Routes to enhanced HIV neuropathogenesis through expression of subclinical levels of endogenous amyloid-beta
通过表达亚临床水平的内源性β淀粉样蛋白增强HIV神经发病机制的途径
- 批准号:
10206405 - 财政年份:2020
- 资助金额:
$ 247.5万 - 项目类别:
Preclinical development of a novel small molecule inhibitor of Alzheimer's disease-related cognitive impairment
阿尔茨海默病相关认知障碍的新型小分子抑制剂的临床前开发
- 批准号:
10159812 - 财政年份:2020
- 资助金额:
$ 247.5万 - 项目类别:
Preclinical development of a novel small molecule inhibitor of Alzheimer's disease-related cognitive impairment
阿尔茨海默病相关认知障碍的新型小分子抑制剂的临床前开发
- 批准号:
10765513 - 财政年份:2020
- 资助金额:
$ 247.5万 - 项目类别:
Preclinical development of a novel small molecule inhibitor of Alzheimer's disease-related cognitive impairment
阿尔茨海默病相关认知障碍的新型小分子抑制剂的临床前开发
- 批准号:
10608172 - 财政年份:2020
- 资助金额:
$ 247.5万 - 项目类别:
The role of SUMOylation in Tau-mediated pathology
SUMO 化在 Tau 介导的病理学中的作用
- 批准号:
10083243 - 财政年份:2019
- 资助金额:
$ 247.5万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 247.5万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 247.5万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 247.5万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 247.5万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 247.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 247.5万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 247.5万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 247.5万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 247.5万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 247.5万 - 项目类别:
Miscellaneous Programs














{{item.name}}会员




